The FDA has approved the use of a blood test to determine if patients have a protein that is prevalent in Alzheimer’s disease. Alisa Nelson talks to Sarah Lovegreen, with the Greater Missouri chapter of the Alzheimer’s Association, who says the new tool is one step...
